Avanzanite Bioscience

📍 Amsterdam, Netherlands🗓 Founded 2021👥 25 employees💰 Last funded Nov 2022
Founded by biopharmaceutical executives, Adam Plich and Anant Murthy, Avanzanite is on a mission to redefine the commercialization of orphan medicines to improve patient access across Europe and beyond. Derived from the word ‘Tanzanite’ – one of the rarest and most underappreciated gemstones on earth – Avanzanite was formed to capitalize on two primary objectives, one economic, and one humanitarian. The economic goal is to offer end-to-end commercialization and distribution partnerships with research-based biopharmaceutical originators to unlock the full value of their orphan medicines in European markets. This is the unique expertise and core competency of our team following decades of operating experience navigating this area. Equally important, our humanitarian goals stem from our commitment to enabling access to novel medicines for patients who suffer from orphan diseases regardless of where in Europe they live. Avanzanite Bioscience B.V. is a fully authorized distributor of medicinal products within the European Economic Area, Switzerland and the UK, with a Wholesale Distributor Authorization (WDA) issued by Farmatec in the Netherlands.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Avanzanite Bioscience?
Avanzanite Bioscience has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Avanzanite Bioscience last raise funding?
The most recent investment in Avanzanite Bioscience recorded on gritt.io was in November 2022.
When was Avanzanite Bioscience founded?
Avanzanite Bioscience was founded in 2021.
What industry is Avanzanite Bioscience in?
Avanzanite Bioscience operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Avanzanite Bioscience based?
Avanzanite Bioscience is headquartered in Amsterdam, Netherlands.